Pitt Shield

Ultrasound programmable hydrogen-bonded organic frameworks for sono-chemogenetics.

Authors: Wang W, Shi Y, Chai W, Kevin Tang KW, Pyatnitskiy I, Xie Y, Liu X, He W, Jeong J, Hsieh JC, Lozano AR, Artman B, Henkelman G, Chen B, Wang H

The precise control of mechanochemical activation within deep tissues via non-invasive ultrasound holds profound implications for advancing our understanding of fundamental biomedical sciences and revolutionizing disease treatments. However, a theory-guided mechanoresponsive materials system with well-defined ultrasound activation has yet to be explored. Here we present the concept of using porous hydrogen-bonded organic frameworks (HOFs) as toolkits for focused ultrasound programmably triggered drug activation to control specific cellular events in the deep brain, through on-demand scission of the supramolecular interactions. A theoretical model is developed to visualize the mechanochemical scission and ultrasound mechanics, providing valuable guidelines for the rational design of mechanoresponsive materials at the molecular level to achieve programmable and spatiotemporal activation control. To demonstrate the practicality of this approach, we encapsulate designer drug clozapine N-oxide (CNO) into the optimal HOF nanoparticles for FUS gated release to activate engineered G-protein-coupled receptors in the mice and rat ventral tegmental area (VTA), and hence achieved targeted neural circuits modulation even at depth 9 mm with a latency of seconds. This work demonstrates the capability of ultrasound to precisely control molecular interaction and develops ultrasound programmable HOFs to minimally invasive and spatiotemporally control cellular events, thereby facilitating the establishment of precise molecular therapeutic possibilities. We anticipate that this research could serve as a source of inspiration for precise and non-invasive molecular manipulation techniques, potentially applicable in programming molecular robots to achieve sophisticated control over cellular events in deep tissues.

Introduction

Purpose Drug delivery WITHOUT BBB opening
Study Objective To develop and demonstrate hydrogen-bonded organic framework nanoparticles that enable focused-ultrasound-programmable release of encapsulated drugs to noninvasively control cellular events in deep brain tissue.
Animal model / Human subject Mice (species: Mus musculus; strain: None; age: None; sex: None) and rat (species: Rattus norvegicus; strain: None; age: None; sex: None)
Targeted brain region(s) Ventral tegmental area
Cargo name and characteristics Clozapine N-oxide (CNO) — a small-molecule designer drug (DREADD ligand) encapsulated in hydrogen-bonded organic framework (HOF) nanoparticles for focused ultrasound (FUS)-gated release to activate engineered G-protein-coupled receptors in the ventral tegmental area

Outcomes and Safety

Summary of Outcomes Focused ultrasound-triggered release of clozapine N-oxide from hydrogen-bonded organic framework nanoparticles activated engineered G-protein-coupled receptors in mouse and rat ventral tegmental area, producing targeted neural circuit modulation at depths up to 9 mm with second-scale latency (specific FUS parameter values None in the abstract).
Duration of biological effect seconds
Safety-related matter The abstract does not report any adverse effects or safety concerns; it describes the approach as "minimally invasive" but provides no safety data or mention of adverse events.

Brain Region

Ultrasound Parameters

Focal Characteristics focal depth: 9 mm; focal length: None; aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search